Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710703) titled 'NWRD09 for Persistent Cervical HPV16 Infection' on July 13. Brief Summary: This is a rando... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712744) titled 'Resilience-Building Intervention for Older Informal Caregivers' on June 30. Brief Summary:... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More
Singapore, July 18 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eval... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710248) titled 'SG301-SC Injection Safety Study in Subjects With Primary ITP Patients' on July 09. Brief S... Read More
U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07712562) titled 'A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With B... Read More